Excedrin — Class III drug recall D-744-2014
Terminated recall by Novartis Consumer Health, reported 2014-01-22, distributed nationwide. Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing
| Recall number | D-744-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Novartis Consumer Health, Lincoln, NE, United States |
| Recall initiated | 2013-05-15 |
| Classified | 2014-01-16 |
| Reported by FDA | 2014-01-22 |
| Terminated | 2014-11-04 |
| Distributed | Nationwide (US) |
| Countries outside the US | EC, PA, VE |
| Reason classes | specification failure |
| NDC | 00067-2062-02 |
| Lot numbers | 05/13, 08/13, 09/13, 10118234, 10120254, 10123513, 10125262 |
Product
Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-744-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.